This page is part of the Pharmaceutical Quality (Industry) (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
Details about drug substance or drug product release and stability specification (tests, acceptance criteria).
MedicinalProductDefinition | The drug product (Stelbat tablets, 20mg) |
Ingredient | The active ingredient (stelbatalol) or the ingredients that make up the drug product |
SubstanceDefinition | Chemical or biological details about substance(s) associated with the ingredient |
PlanDefinition | Describes the specification set of tests |
ObservationDefinition | Each individual test and acceptance criteria; also used to group closely related tests |
Organization | (not illustrated above): The company/site that performed the testing or manufacturing |
eCTD section synthetic source data samples (PDF):
XML and JSON examples of synthetic CTD data:
HTML presentation example of synthetic CTD data:
SubstanceDefinition | The substance which this is a specification for |
PlanDefinition | Describes the specification set of tests |
ObservationDefinition | Each individual test and acceptance criteria; also used to group closely related tests |
eCTD section synthetic source data samples (PDF):
XML and JSON examples of synthetic CTD data:
HTML presentation example of synthetic CTD data: